ewan k. cobran, ph.d. curriculum vitae...ewan k. cobran, ph.d. curriculum vitae page 3 depression...

October 15, 2020

Curriculum Vitae Ewan K. Cobran, Ph.D.

Assistant Professor University: Department of Clinical and Administrative Pharmacy Division of Pharmaceutical Health Services, Outcomes, and Policy University of Georgia College of Pharmacy Robert C. Wilson Pharmacy 250 West Green Street, Suite 270B Athens, GA 30602 Email: [email protected] Telephone: (706) 542-5327

Statement of Research Interest

Dr. Cobran’s research investigates the relationship(s) between medically underserved populations, genetic literacy, patient-provider communications, and prostate cancer disparities. Specifically, his work focuses on three main lines of scientific inquiry: (1) applying Community-based Participatory Research and Epidemiological Approach to evaluate genetic literacy, awareness, barriers, and facilitators to implementation of prognostic genetic technology dissemination in African-American and Rural White men with localized prostate cancer; (2) the impact of health social determinants (e.g. socioeconomic status, literacy, nativity, social integration, community structure, quality of care) on prostate cancer prevention, barriers to treatment, and treatment related outcomes; and (3) connections between Androgen Deprivation Therapy (ADT) associated comorbid health conditions (e.g., diabetes, myocardial infarction, and cardiovascular disease) and survival; analyzing whether these health conditions vary by race and ethnicity for men with advanced prostate cancer. His scholarship includes secondary data analysis (i.e., Surveillance, Epidemiology, and End Results (SEER) cancer registry, Medicare Claims Database), community-based participatory research, and implementation of evidenced-based behavioral interventions.

Dr. Cobran conducted primary data collection, using a community-based participatory research approach to investigate the relationship between perceptions of prostate cancer fatalism, treatment, screening by disaggregating African-American males into United States-born and Caribbean-born, for his Ph.D. thesis. He collaborated with researchers from the African-Caribbean Cancer Consortium, the University of Florida, the University of the West Indies Mona, Fox Chase Cancer Center, and the National Cancer Institute to: (1) develop a survey instrument measuring perceptions of prostate cancer fatalism, screening barriers, and the influence of acculturation on early prostate cancer detection, (2) validate the adaption of the Powe Fatalism Inventory among United States-born and Caribbean-born African American males by conducting four qualitative focus groups, and (3) collect quantitative data from 245 participants in South Florida to complete his Ph.D. thesis. During his National Cancer funded Cancer Health Disparities Training Program (T32) Postdoctoral Fellowship at the University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, he was awarded a North Carolina Translation and Clinical Science Institute (NC TraCS) pilot grant for his research evaluating racial differences in survival and use of androgen deprivation therapy for treatment of metastatic prostate cancer. This quantitative research analysis using SEER-Medicare data examined racial disparities in commencement of androgen deprivation therapy, and racial differences in survival outcomes among men diagnosed with metastatic prostate cancer.

Dr. Cobran’s current research directly addresses: (1) the dissemination and utilization of prognostic genetic testing in African-American and Rural White men with localized prostate cancer in order to enhance the understanding of patient-caregiver genetic decisional support; (2) the burdens of racial disparities in prostate cancer outcomes by evaluating whether minority males are at higher risk of treatment related comorbidities, and the impact of treatment related comorbidities on survival; and (3) reduction in health disparities in cancer treatment outcomes for medically underserved populations by investigating improvements to community infrastructure, barriers to care, and continuity of care.

Ewan K. Cobran, Ph.D. Curriculum Vitae

Education University of North Carolina at Chapel Hill, Postdoctoral Fellowship in Cancer Health Disparities, September 1, 2012 – August 15, 2014

University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center, Gillings School of Global Public Health, and School of Medicine, Chapel Hill, NC Research Concentration: Disparities in Cancer Outcomes and Survivorship

Faculty Mentors – Drs. Paul A. Godley, Betsy Sleath, Til Sturmer, and Geni Eng.

Howard University, College of Pharmacy, Washington, D.C. – Ph.D. in Pharmaceutical Science, May 2012

Research Concentration: Pharmaceutical Health Service Research, Pharmacoepidemiology, and Pharmaceutical Outcomes/Policy

Faculty Mentor – Dr. Anthony K. Wutoh

• Dissertation Title: “Cross-Comparison of Native-born and Caribbean-born African American Males: Prostate Cancer Fatalism, Screening, and Perceptions of Treatment”

University of Florida, College Health and Human Performance, Gainesville, Florida – B.S. in Health Science with honors, May 2006

Ronald E. McNair Scholars Program, May 2005 – April 2006 University of Florida, College of Pharmacy, Gainesville, FL Research Concentration: Pharmaceutical Outcomes and Policy

• Documented the extent of misinformation concerning drug-drug and drug-food warning interactions among dispensed medications containing Statins, Warfarins, and Nitrates.

Faculty Mentor – Dr. Earlene Lipowski

University Scholars Program, May 2004 – April 2005 University of Florida, College of Pharmacy, Gainesville, FL Research Concentration: Pharmaceutical Outcomes and Policy

• Measured the effectiveness and adoption of an internet application and personal digital assistant device in terms of penetration and intensity of use for the Florida Medicaid Pharmacy Services.

Faculty Mentor – Dr. Richard Segal

Experience Assistant Professor (Tenure-Track), University of Georgia, College of Pharmacy, Department of Clinical and Administrative Pharmacy, Pharmaceutical Health Services, Outcomes, and Policy, Athens, Georgia, August 2014 – Present

• Develop and co-develop courses in Pharmacoepidemiology, Pharmacy Health Services and

Outcomes, Pharmacy and United States Health Care System, Research Methods in Pharmacy Administration, and Pharmaceutical Health Services, Outcomes, and Policy Special Topics Seminar.

• Awarded Harvard Medical School Research Methods in Supportive Oncology Scholar (2020) by Dana-Farber Cancer Institute Department of Psychosocial Oncology and Palliative Care.

• Mentor and advise five Ph.D. students, serving on their doctoral thesis committees, and providing applied behavioral and qualitative research instruction.

• Supervised and co-authored five manuscript submissions with doctoral students: (1) Cost utility analysis of Methylphenidate and Amphetamine/Dexamphetamine in adults with Attention-deficit hyperactivity disorder – in the Journal of Pharmaceutical Health Service Research, (2) Race and Timing of Androgen Deprivation Therapy among Men with Metastatic Prostate Cancer: A Surveillance, Epidemiology, and End Results Medicare Analysis – in the Journal of American Cancer Society – Cancer, (3) Impact of Cryotherapy and Conservative Management on


Depression and Anxiety Disorder in Men with Prostate Cancer – in the Journal of Psychosocial Oncology, (4) An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer – in the Journal of Pharmacoeconomics, and (5) Comparative Effectiveness of Conservative Management versus Cryotherapy in Localized Prostate Cancer Patients: An Analysis of Treatment Related Side-effects and Survival – in the Journal of Clinical Oncology.

• Awarded Inaugural 2019 Recipient of The Jonice A. Louden Young Investigator Award by The African-Caribbean Cancer Consortium.

• Selected by the Georgia Clinical & Translational Science Alliance as a KL2-Mentored Clinical and Translational Research Scholar, 2019-2021.

• Selected by the National Cancer Institute Cancer Prevention Program as a 2019 Scholar to attend the Summer Curriculum in Cancer Prevention and Control – Molecular Prevention Course.

• Awarded a 2018 International Travel Award by the Prostate Cancer Transatlantic Consortium. • Selected by the National Cancer Institute Cancer Prevention Program, as 2017 Summer Curriculum

in Cancer Prevention and Control Scholar. • Selected as a University of Oxford 2017 Summer Scholar in Real World Data Epidemiology –

Center for Statistics in Medicine (CSM), Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Musculoskeletal Pharmaco- and Device Epidemiology Group.

• Selected by the National Institute on Minority Health and Health Disparities as a 2015 Translational Health Disparities Scholar.

• Selected as a Geographic Management of Cancer Health Disparities Programs (GMaP) Region 2 Scholar – H. Lee Moffitt Cancer Center.

• Recipient of the Owens Institute for Behavioral Research Mentoring Program Award (2015-2017) • Awarded a 2015 American Cancer Society Institutional Research Pilot Grant. • Co-investigator on a Randy Ellison Cancer Research Fund at the University of Georgia College of

Pharmacy. • Co-investigator on Clinical and Translational Research Unit at the University of Georgia Research

Grant. • Served as a judge for the American Pharmacists Association Annual Meeting & Exposition for the

Economic, Social, and Administrative Science (ESAS) Contributed Research Papers. • Served as a judge for the International Society for Pharmacoeconomics and Outcomes Research

21th Annual International Meeting, Research Podium Presentation – Session 1. • Manuscript reviewer for Medical Care, International Journal of Pharmacy Practice, American

Journal of Men’s Health, Health Education and Behavior, and Journal of Immigrant and Minority Health.

• Presented numerous oral and written research abstracts at international, national, and regional conferences including the International Society for Pharmacoeconomics and Outcomes Annual European Congress, International Society of Pharmacoeconomics and Outcomes Research Annual Meeting, Science of Global Prostate Cancer Disparities, American Cancer Society Biennial Cancer Survivorship Research Conference, American Pharmacists Association (APhA) Annual Meeting & Exposition, 10th Annual University of Alabama at Birmingham Health Disparities Research Symposium, and the 8th Biennial Cancer Survivorship Research Conference: Innovation in a Rapidly Changing Landscape – American Cancer Society.

Adjunct Assistant Professor, University of North Carolina at Chapel Hill, Gillings School of Global Public Health, Department of Health Behavior, Chapel Hill, North Carolina, August 2014 – Present

• Developed a funded research study focused on patient navigation services and intermediate

patient health outcomes in prostate cancer patients. • Mentored and supervised a doctoral student in survey research development and implementation • Introduce students to community-based participatory and community engagement research

approach. • Conducted analysis of the Surveillance, Epidemiology, and End Results (SEER) Medicare data

investigating racial disparities in diffusion of intensity-modulated radiation therapy for localized for prostate cancer.


Management & Program Analyst, Visiting Summer Scholar, United States Department of Homeland Security, Office of Health Affairs, Workforce Health Protection & Medical Support, Washington, District of Columbia, May 24, 2010 – August 13, 2010; June 6, 2011 – August 12, 2011

• Wrote the Department of Homeland Security (DHS) Components Technical Guidance for Medical

Counter Measures (MCM) Storage of Ciprofloxacin and Doxycycline. • Developed the DHS Tamiflu Inventory Questionnaire for DHS Antiviral Tracking (surveyed DHS

Components (CBP, OSEP, and ICE), and achieved a 92% survey response rate). • Wrote the Domestic Pharmaceutical Production of Antibiotics Section of the Office of Health

Affairs Anthrax White Paper. • Reviewed the Standard Operation for Medical Counter Measures for Doxycycline and

Ciprofloxacin. • Collaborated on the Technical Guidance for Medical Counter Measures (MCM)

Distribution/Dispensing for DHS Personnel in Response to an Anthrax Event. Graduate Teaching Assistant, Introduction to Biostatistics and Research Methods with SPSS, Howard University, College of Pharmacy, Department of Clinical and Administrative Pharmacy, Washington, District of Columbia, August 24, 2009 – December 10, 2010

• Introduced students to the elements of scientific research, the scientific process, and the role of research in clinical and pharmaceutical care.

Graduate Research Assistant, Pharmerit North America LLC, Bethesda, Maryland, January 5, 2009 – September 25, 2009

• Conducted an extensive literature review of Plasmodium falciparum malaria infection and

vaccination. • Collaborated in writing the epidemiology section of a malaria vaccine product economic

positioning. • Contributed to a malaria vaccine product economic positioning documenting the malaria vaccine

developmental story and future treatment expansion. Graduate Teaching Assistant, Introduction to SAS Programming and Data Analysis, Howard University, College of Pharmacy, Department of Clinical and Administrative Pharmacy, Washington, District of Columbia, January 07, 2009 – May 9, 2009

• Introduced students to the use of the SAS analytical package for the management and analysis

of statistical data. • Contributed to the application of the SAS programming language to Health Service Research.

Research Data Abstracter, Science Application International Corporation (SAIC), Rockville, Maryland, October 14, 2008 – March 10, 2009

• Research Reviewer (title, author, abstract, full text, and publication) applying

specific inclusion and exclusion criteria pertaining to a national cholesterol guideline study. • Identified data to be abstracted and entered into a web-based data collection system.

Health Intern, United States Department of Health and Human Service, Office of Minority Health, Quality Education for Minorities Network, Washington, District of Columbia, May 26, 2008 – August 2, 2008

• Developed a global demographic profile of HIV/AIDS. • Documented the incidence and prevalence of HIV/AIDS among women, children, and the poor. • Completed America Red Cross Training in Blood Borne Pathogens, HIV/AIDS Starter Facts,

Basic HIV/AIDS Education & Prevention, and African American HIV Education & Prevention.


Graduate Research Assistant, Association of Occupational and Environmental Clinics, Washington, District of Columbia, November 5, 2007 – May 22, 2008

• Measured the effectiveness of the Pediatric Environmental Health Specialty Units (PEHSU) in

their mission of research productivity and educational outreach. • Collaborated on a manuscript which documented the scholarly productivity of Pediatric PEHSU

in the United States. • Reviewed AOEC’s grant proposals for submission to the National Institute of Health.

Summer Research Intern, Pharmerit North America LLC, Bethesda, Maryland, July 5, 2007 – August 30, 2007

• Conducted an extensive literature review of S. pneumoniae infection and vaccination. • Abstracted published clinical and experimental data pertaining to vaccination coverage. • Produced a final report on S. pneumoniae vaccine coverage and herd immunity.

Research Assistant, Center for Minority Health Service Research, Howard University, Washington, District of Columbia, January 1, 2007 – July 30, 2007

• Organized advisory review panel meetings for a HIV/AIDS Study. • Provided research project management for a HIV prevention and feasibility study. • Attended community outreach venues to promote research initiatives.

Student Intern, Centers for Medicare and Medicaid Service, Florida Department of Elder Affairs, Serving Health Insurance Needs of Elders Program, Gainesville, Florida, January 3, 2006 – April 30, 2006

• Counseled and enrolled seniors in the Medicare Part D Prescription Drug Benefit Program during the programs’ implementation in 2006.

• Hosted monthly community outreach site visits for seniors in regard to Medicare Part D. • Attended Medicare initiative training meetings in Northern Florida. • Developed an understanding of health care and pharmaceutical disparities in health care quality

and access.

Outstanding Achievements Harvard Medical School Research Methods in Supportive Oncology Scholar (2020) awarded by Dana-Farber Cancer Institute Department of Psychosocial Oncology and Palliative Care. Jonice A. Louden Young Investigator Award – Inaugural Recipient (2019) awarded by The African-Caribbean Cancer Consortium. National Center for Advancing Translation Science Diversity Research Supplement – Inaugural Recipient, Georgia Clinical and Translational Science Alliance and the University of Georgia (2019). Georgia Clinical & Translational Science Alliance (CTSA), KL2-Mentored Clinical and Translational Research Scholar, 2019-2021. National Cancer Institute Cancer Prevention Program, Summer Curriculum in Cancer Prevention and Control – Molecular Prevention, 2019 Scholar. Sr. Vice President for Academic Affairs & Provost at the University of Georgia, 2018 International Travel Award.


Prostate Cancer Transatlantic Consortium 2018 International Travel Award. National Cancer Institute Cancer Prevention Program, Summer Curriculum in Cancer Prevention and Control 2017 Scholar. University of Oxford 2017 Summer Scholar in Real World Data Epidemiology, Center for Statistics in Medicine (CSM), Nuffield Department of Orthopedics, Rheumatology and Musculoskeletal Sciences (NDORMS), Musculoskeletal Pharmaco- and Device Epidemiology Group.

Lilly Teaching 2017-2019 Fellow, University of Georgia Center for Teaching Learning Geographic Management of Cancer Health Disparities Programs (GMaP) Region 2 Scholar - Navigate Your Way to a K Award, Targeted Training Workshop funded by the National Cancer Institute (GMaP Grant No. 3P30CA076292-17S4). The National Institute on Minority Health and Health Disparities 2015 Translational Health Disparities Scholar. Prostate Cancer Disparities Travel Award, to attend the 2nd Biennial Science of Global Prostate Cancer Disparities Conference in Nassau, Bahamas, October 2012 ($500.00). African-Caribbean Cancer Consortium Travel Award, supported by the National Cancer Institute – Epidemiology Genetic Research Program, to attend the 4th Annual International African-Caribbean Cancer Consortium Conference, July 2012 ($1,500.00). American Association of Pharmaceutical Scientists Award, for outstanding performance as the 2010-2011 Vice-Chair of Howard University Chapter, May 2011. Invited Reviewer of Abstracts, International Society for Pharmacoeconomics and Outcomes Research – 16th Annual International Meeting, May 2011. 8thAnnual Quantitative Training Award, funded by the National Science Foundation, Society of Multivariate Experimental Psychology, and the American Psychological Association, April 2011. African-Caribbean Cancer Consortium Student Travel Award, to attend the 3rd Annual International African-Caribbean Cancer Consortium Conference, November 2010. Vice-Chair, American Association of Pharmaceutical Scientists Howard University Chapter, 2010-2011. DHS Gold Medal & Letter of Appreciation – Chief Medical Officer of the U.S. Department of Homeland Security, Office of Health Affairs, awarded for outstanding contribution to the Department of Homeland (DHS) Technical Guidance for Antibiotic Storage, and the Medical Countermeasure (MCM) Annex to the Departmental Guidance Statement on Anthrax Response (DGS), August 2010. Howard University Graduate Trustee Scholar, awarded for outstanding academic achievements, in the amount of $37,995, June 2010. Howard University Graduate School Summer Travel Award, to attend the 14th Annual Summer Institute in Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health, in the amount of $1,428, May 2010. Invited Reviewer of Abstracts, International Society for Pharmacoeconomics and Outcomes Research – 13th Annual European Congress, March 2010. Treasurer, American Association of Pharmaceutical Scientists Howard University Chapter, Fall 2009.

Research Support

Grant Activity: Grant Period “Title” Source * Total Funding as PI (2014-2020): $1,485,078.00 ‡ Total Funding as PI (2014-2020) + Pending Funding (R03): $1,646,896.00


Active 09/30/2020 – 01/08/2025 (Cobran-PI) National Cancer Institute (K01) - $862,985.00 Mentored Research Scientist Development Award (PAR-18-365) Genetic Literacy and Patient-Caregiver Communication of Prognostic Genetic Technology for Localized Prostate Cancer Role: Principal Investigator 09/01/2020 – 07/30/2022 (Cobran-PI) National Institute on Minority Health and Health Disparities (L60) - $100,000.00 Extramural Loan Repayment Program for Health Disparities Research (NOT-OD-19-118) Genomic Comprehension in Rural White and African-American Men with Localized Prostate Cancer Role: Principal Investigator

04/23/2019 – 06/30/2021 (Cobran-PI)

National Center for Advancing Translational Sciences - $422,718.00

Research Supplements to Promote Diversity in Health-Related Research (PA-18-906)

Facilitators and Barriers to the Comprehension for the Application of Genomic Technology for Prognostic Testing among Rural White and African-American Men with Localized Prostate Cancer

Role: Principal Investigator 06/01/2019 – 06/30/2021 (Cobran-PI)

Winship Cancer Institute of Emory University - $12,500.00

Development and Pilot Test of a Video-based Educational Tool for The Comprehension of Common Prognostic Genomic Terminology for Prostate Cancer

Role: Principal Investigator Pending 11/01/2020 – 08/31/2025 (Bartlett-PI) Food and Drug Administration (U01) – $4,999,996.00 Drug Development Science Support Cooperative Agreement (RFA-FD-20-033)


The Center for Accelerated Patient and Stakeholder Engagement Role: Real-World Evidence and Big Data Consultant

09/01/2021 – 07/30/2023 (Cobran-PI) National Cancer Institute (R03) - $161,818.00 Small Grants Program for Cancer Research (PAR-18-021) Morality and Thromboembolic Events in Castration-resistant Prostate Cancer Patients with Pre-existing Cardiovascular Comorbidities Receiving Second-Generation Androgen Deprivation Therapy Role: Principal Investigator

Completed

07/01/2018 – 06/30/2019 (Cobran-PI)

Owens Institute for Behavioral Research, University of Georgia - $5,000.00

Utilization of Prognostic Genetic Testing for Localized Prostate Cancer

Role: Principal Investigator

08/01/2018 – 06/30/2019 (Cobran-PI)

Lilly Fellow Program, Center for Teaching and Learning, University of Georgia - $2,000.00

Instructional Improvement in Pharmaceutical Epidemiology and Health Outcomes Research for Doctoral and Pharmacy Students

Role: Principal Investigator

American Cancer Society - $40,000.00

07/01/2015 – 10/31/2017

Quality of Life, Racial Differences, and Risk of Androgen Deprivation Therapy Associated Diabetes, MI, and CVD during Treatment for Advance Prostate Cancer: A Surveillance, Epidemiology, and End Results (SEER) Linked Medicare Part D and Medicare Health Outcomes Survey Analysis.

Role: Principal Investigator University of Georgia College of Pharmacy Randy Ellison Cancer Research Fund - $1,500.00

09/11/2015 – 10/31/2017


Barriers to the Utilization of Preventive Health Services and Adoption of Healthy Lifestyle Behaviors among Postmenopausal Breast Cancer Survivors.

Role: Co-Principal Investigator University of Georgia Clinical and Translational Research Unit - $30,000.00

12/15/2015 – 10/31/2017 Effect of a Physical Activity and Healthy Eating Intervention Compared to a Mindful Eating Intervention on Biomarkers of Cancer Prognosis in Overweight and Obese Breast Cancer Survivors.

Role: Co-Principal Investigator Navigate Cancer Foundation - $6,375.00

10K1270044 Cobran (PI) 03/01/2013 – 12/01/2015

Associations Between the Independent Specialty Medical Advocate Model of Patient Advocacy Services and

Intermediate Patient Health Outcomes in Prostate Cancer Patients

Role: Principal Investigator North Carolina Translation & Clinical Science Institute - $2,000.00

2KR491305 Cobran (PI) 07/01/2013 – 6/01/2014

Evaluating Racial Differences in Survival and Use of Androgen Deprivation Therapy for Metastatic Prostate Cancer Using the Surveillance, Epidemiology, and End Results Cancer Registry and Medicare Claims Database. Role: Principal Investigator

National Cancer Institute - $164,158.00

5T32CA128582-043 Eng (PI) 09/01/2012 – 08/01/2014 The Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant (T32) University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Cancer Health Disparities Training Program Role: Postdoctoral Fellow


Grant Submissions

07/01/2018 – 06/20/2023 (Cobran-PI) National Institute of Health - $843,320.00 Genetic Literacy and Patient-Caregiver Communication of Prognostic Genetic Technology for Localized Prostate Cancer Role: Principal Investigator 07/01/2018 – 06/30/2019 (Cobran-PI) American Association for Cancer Research - $75,000.00 Gertrude B. Elson Cancer Research Award Translation and Utilization of Prostate Cancer Prognostic Genomic Panels Role: Principal Investigator 01/01/2018 – 12/31/2018 (Cobran-PI) Georgia Clinical & Translational Science Alliance - $39,928.00 Genetic Literacy and Utilization of Prognostic Genetic Testing for Localized Prostate Cancer Role: Principal Investigator 07/01/2017 – 06/30/2019 (Cobran-PI) Georgia Clinical & Translational Science Alliance - $220,694.00 Genetic and Genomic Literacy and Facilitators for Adoption of New Genomic Technology in Rural Men at-risk for Prostate Cancer Role: Principal Investigator 07/01/2017 – 06/30/2018 (Cobran-PI) United States Department of Health and Human Service - $17,823.00 Southern Summer Health Equity Institute Role: Principal Investigator


08/07/2017 – 08/06/2018 (Cobran-PI) Robert Wood Johnson Foundation - $50,000.00 Examining Accuracy and Quality of Novel Genomic Biomarkers for Prediction of Prostate Cancer Risk, Response to Therapy, and Prognosis Role: Principal Investigator

12/01/2015 – 11/30/2017 (Cobran-PI) National Cancer Institute - $150,000.00 Racial Differences in Risk of ADT Associated MI and CVD during Treatment for Advanced Prostate Cancer: A Surveillance, Epidemiology, and End Results (SEER) Medicare Analysis Role: Principal Investigator 08/03/2015 – 08/02/2017 (Cobran-PI) Pharma Foundation - $100,000.00 Risk of Androgen Deprivation Therapy-Induced Myocardial Infarction and Cardiovascular Disease during Treatment for Advanced Prostate Cancer Role: Principal Investigator

Peer-Reviewed Publications

† Indicates Graduate Student Co-Author † Asiri IM, Young HN, Mandawat A, Master V, Codling J, Beach S, Rajbhandari-Thapa J, Cobran EK. (2020).

Race and Prostate Specific Antigen Surveillance Testing and Monitoring 5-years after Definitive Therapy for Localized Prostate Cancer. Nature: Prostate Cancer and Prostatic Disease – Revise and Resubmit.

† Asiri IM, Chen RC, Young HN, Mandawat A, Master V, Beach S, Rajbhandari-Thapa J, Cobran EK. (2020).

Thromboembolic Events in Castration-Resistant Prostate Cancer Patients with Pre-existing Cardiovascular Comorbidities Receiving Oral Androgen Signaling Inhibitors. Journal of Oncology Practice – Under Review.

† Asiri AM, Chen RC, Beach S, Master V, Mandawat A, Cobran EK. (2020). Mortality in Castration-Resistant

Prostate Cancer Patients with Pre-existing Cardiovascular Comorbidities Receiving Oral Androgen Signaling Inhibitors. Journal of Urology – Under Review.

Francisco MI, Claire R, Rina D, Thapa J, Cobran EK, Martin W, Faustine W. (2020). Identifying Risk Subgroups

of Invasive Prostate Cancer Surgical Delay using a Person-centered Approach: The constellation of health determinants using latent class analysis on cancer registry data. American Journal of Men’s Health – Under Review.


† Wang Y, Young HN, Cobran EK, Perri M. (2020). Patient, Physician and Organizational Influences in Variation

of Physician Prescribing Behavior. British Medical Journal Quality and Safety – Under Review. Cobran EK, Young HN, Chen RC, Chen X, Reeves J, Godley PA, Shah S (2019). Race and Timing of Androgen

Deprivation Therapy among Men with Metastatic Prostate Cancer. Journal of the National Medical Association. S0027-9684(18)30168-8.

† Alwhaibi A, Kolhe R, Gao F, Cobran EK, Somanath PR. (2019). Genome Atlas Analysis based Profiling of Akt

Pathway Genes in the Early and Advanced Human Prostate Cancer. Oncoscience. 6(5-6):317-336. doi: 10.18632/oncoscience.482.

† Shah S, Cobran EK, Young H. (2018). An Economic Evaluation of Conservative Management and Cryotherapy

in Patients with Localized Prostate Cancer. Journal of Pharmaceutical Health Services Research. doi: 10.1111/jphs.12248. † Shah S, Young H, Cobran EK. (2018). Comparative Effectiveness of Conservative Management versus

Cryotherapy in Localized Prostate Cancer Patients. American Journal of Men’s Health. 12(5):1681-1691. doi: 10.1177/1557988318781731.

† Shah S, Wei H, Jayawardhana J, Perri M, Cobran EK, & Young H. (2017). Cost utility analysis of

Methylphenidate and Amphetamine/Dexamphetamine in adults with Attention-deficit hyperactivity disorder. Journal of Pharmaceutical Health Services Research. doi:10.1111/jphs.12173.

Cobran EK, Merino Y, Roach B, Bigelow SM, & Godley PA (2017). A feasibility study of the independent

specialty medical advocate model of patient navigation on intermediate health outcomes in newly diagnosed cancer patients. Journal of Oncology Navigation & Survivorship. 8(10):462-470.

Cobran EK, Hall JN, & Aiken W. (2017). African-American and Caribbean-born men’s perceptions of prostate

cancer fear and facilitators for screening behavior: A pilot study. Journal of Cancer Education. doi:10.1007/s13187-017-1167-x.

Cobran EK, Chen RC, Overman R, Meyer AM, Kuo M, Sturmer T, Sheets N, Goldin GH, Pen D, Godley PA, Carpenter WR. (2016). Racial Disparities in Diffusion of Intensity-Modulated Radiation Therapy for

Localized for Prostate Cancer. Am J Men’s Health. doi: 10.1177/1557988314568184.

Cobran EK, Wutoh AK, Lee E, Odedina F, Ragin C, Aiken W, and Godley P. (2014). Perceptions of Prostate Cancer Fatalism and Screening Behavior Between United States-born and Caribbean-born Black Males. J Immigr Minor Health. 16(3):394-400.

Pen D, Stitzenberg K, Cobran EK, Godley PA. (2014). Provider-based Research Network Demonstrate Greater

Hospice Use for Minority Patients with Lung Cancer. J Oncol Pract. 10(4):e182-90. Wutoh AK, Nichols-English G, Daniel M, Kendall KA, Cobran EK, et al. (2011). Pilot Study to Assess HIV Knowledge Spirituality, and Risk Behaviors Among Older African Americans. J Natl Med Assoc. 103:265-268.

Peer Reviewed Publications in Preparation for Submission

Cobran EK, Asiri AM, Beach S. Perceptions of Prostate Cancer Fatalism and Predictors of Screening in Multiethnic Black Men: A Retrospective Partial Least Squares Structural Equation Modeling Analysis. Journal of Health Education and Behavior

Cobran EK, Young HN, Asiri IM, Rivers B, Master V, Beach S. Development of a Video-based Educational Tool

for Genomic Comprehension in African-American and Rural White Men with Localized Prostate Cancer. Cancer.


Cobran EK, Young HN, Asiri IM, Rivers B, Master V, Beach S. Patient Satisfaction with Provider

Communication Regarding Prostate Cancer Genetic Testing for Men with Localized Prostate Cancer. Journal of Cancer Survivorship.

Cobran EK, Young HN, Asiri IM, Rivers B, Master V, Beach S. Patient-provider Genetic Communication among

Rural Men Newly Diagnosed with Prostate Cancer. Medical Care.

Asiri AM, Young HN, Master V, Mandawat A, Cobran EK. A Nested New-User Design for Time to First Initiate Opioids in Castration-Resistant Prostate Cancer Patients. American Journal of Public Health.

Cobran EK, Young HN, Rivers B, Master V, Beach S. Genetic Literacy and Patient-Caregiver Communication

of Prognostic Genetic Technology for Localized Prostate Cancer. JAMA Oncology.

Peer-Reviewed Abstracts

† Indicates Graduate Student Co-Author ‡ Denotes Invited †Asiri IM, Cobran EK. (2020). Prostate Specific Antigen Testing as a Disease Surveillance Tool 5-years after

Definitive Therapy for Localized Prostate Cancer. American Society of Clinical Oncology Annual Meeting, McCornick Place, Chicago, Illinois.

†Asiri IM, Young HN, Beach S, Mandawat A, Master V, and Cobran EK. (2020). Mortality and Thromboembolic

Events in Castration-Resistant Prostate Cancer Patients with Pre-existing Cardiovascular Comorbidities Receiving Oral Androgen Signaling Inhibitors: Research In-progress. Poster session presented at The Southeast Regional Clinical & Translational Science Conference.

‡ Cobran EK, Chen R, Godley PA, Beach S, Young HN, Shah S, Asiri IM. (2019) Prostate

Specific Antigen Surveillance Testing Frequency after Definitive Treatment with Surgery and Radiation Therapy for Localized Prostate Cancer. The 7th African Caribbean Cancer Consortium Scientific and Training Conference, Kingston Jamaica – Jonice A. Louden Young Investigator Award Research Presentation – Inaugural Award Recipient

‡ Cobran EK, Asiri IM (2019) The Multiethnic Prostate Cancer, Fatalism, and Screening

Model: A Retrospective Partial Least Squares Structural Equation Modeling Analysis. The 7th African Caribbean Cancer Consortium Scientific and Training Conference, Kingston Jamaica

‡ Cobran EK, Young HN, Shah S. (2019). The Impact of Cryotherapy Compared to Conservative Management

on Newly Diagnosed Mental Health Disorders in Men with Localized Prostate Cancer. Southeastern Symposium on Mental Health.

Cobran EK, Chen RC, Chen X, Reeves J, Godley P, Shah S. (2018). Race and Receipt of Androgen Deprivation Therapy among Men with Metastatic Prostate Cancer. Poster session presented at Georgia Clinical &

Translational Science Conference. Cobran EK, Merino Y, Roach B, Bigelow SM, & Godley PA (2018). A Pilot Study of the Independent Specialty

Medical Advocate Model of Patient Navigation on Intermediate Health Outcomes in Newly Diagnosed Cancer Patients. Poster session presented at Georgia Clinical & Translational Science Conference.

† Shah S, Young HN, Cobran EK. (2018). An Economic Evaluation of Conservative Management and

Cryotherapy in Patients with Localized Prostate Cancer. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 23rd Annual Meeting.


† Shah S, Cobran EK, Young H. (2017). The Impact of Cryotherapy and Conservative Management on

Depression and Anxiety Disorders in Men with Prostate Cancer. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 22nd Annual Meeting.

† Kanchanasuwan S, Cobran EK, Young H. (2017). Changes in Disability Days in Young Adults After the

Extended Dependent Coverage Under the Affordable Care Act. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 22nd Annual Meeting.

† Shah, S., Young, H., & Cobran, EK. (2016). The Impact of Cryotherapy Compared to

Conservative Management on Overall Survival in Localized Prostate Cancer Patient. Poster session presented at the 8th Biennial Cancer Survivorship Research Conference: Innovation in a Rapidly Changing Landscape.

† Wang, Y., & Cobran, EK. (2016). Association between Affordable Care Act-covered Preventive

Care Use and Emergency Room Visits and Costs. Poster session presented the meeting of International Society for Pharmacoeconomics and Outcomes Research, 21th Annual Meeting.

† Shah, S., Cobran, EK, & Young, H. (2016). Comparative effectiveness of conservative

management versus cryotherapy in localized prostate cancer patients: An analysis of treatment-related complications and survival. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 21th Annual Meeting.

† Kanchanasuwan, S., Cobran, EK, & Young, H. (2016). Predicting hospital readmissions using the LACE index: Results from the Medical Expenditure Panel Survey. Poster session presented at the meeting of International Society of Pharmacoeconomics and Outcomes Research, 21th Annual Meeting.

Cobran EK, Godley PA. (2015). Social Determinants for Diffusion of Intensity-Modulated Radiation Therapy Compared to Conformal Radiotherapy for Localized Prostate Cancer. American Pharmacists Association (APhA) Annual Meeting & Exposition.

Cobran EK, Godley PA, Carpenter W. (2015). Racial Differences in Diffusion of Intensity-Modulated Radiation Therapy for Localized Prostate Cancer. 10th Annual University of Alabama at Birmingham Health Disparities Research Symposium.

Cobran EK, Overman R, Carpenter WR, Godley PA, Chen RC. (2013). Racial Disparities in Diffusion, Comparative Morbidity, and Disease Control of Intensity-Modulated Radiation Therapy Compared to Conformal Radiation Therapy for Localized for Prostate Cancer. International Society for Pharmacoeconomics and Outcomes Research 16th Annual European Congress.

Cobran EK, Wutoh AK, Godley PA. (2012). Cross-Comparison of Native-born and Caribbean-born African American Males: Prostate Cancer Fatalism, Spirituality, and Perceptions of Treatments. The 2nd Biennial Science of Global Prostate Cancer Disparities Conference, Nassau, Bahamas.

Cobran EK, Godley PA. (2012). A Quantitative and Qualitative Assessment of U.S.-born and Caribbean- born African American Males in South Florida: Prostate Cancer Screening, Nativity, and Fatalism. UNC Lineberger Comprehensive Cancer Center 37th Annual Symposium, Chapel Hill, NC.

Cobran EK, Wutoh AK. (2012). A Pilot Study for Cross-Comparison of Native-born and Caribbean-born African American Males: Prostate Cancer Fatalism, Spirituality, and Perceptions of Treatments. The 4th Annual International African-Caribbean Cancer Consortium Conference, Philadelphia, Pennsylvania.

Cobran EK, Daniel MG, Wutoh AK. (2011). Predisposing and Enabling Factors Associated with Physician Avoidance and Perceived 5-year Cancer Survival among Minority Males: Results from the 2007 Health Information National Trends Survey Dataset. New England Science Symposium, Harvard Medical School


Cobran EK, Wutoh AK, Daniel MG. (2010). Factors Associated with Perceived 5-year Cancer Survival Among Minority Males: Results from the 2007 Health Information National Trends Survey (HINTS) Dataset, Updated February 2009. The 3rd Annual International African-Caribbean Cancer Consortium Conference, Miami, Florida.

Cobran EK, Kendall K, Daniel MG, Nichols-English G, Clarke-Tasker V, Hodges G, Lee E, Wutoh AK. (2010). Feasibility of an ACASI Survey Methodology in the Assessment of Spirituality, HIV Knowledge, and Risk Behaviors in Older African Americans. New England Science Symposium, Harvard Medical School.

Acknowledgements

Snedecor SJ, Strutton DR, Ciuryla V, Schwartz EJ, et al. (2009). Transmission-dynamic model to capture indirect effects of infant vaccination with Prevnar (7-valent pneumococcal conjugate vaccine PCV7) in older population. Vaccine. 27:4694-4703.

Professional Affiliations

American Society for Clinical Oncology

International Society for Pharmacoeconomics and Outcomes Research

American Pharmacists Association

American Association of Pharmaceutical Scientists

Golden Key International Honor Society

Academy Health

American Public Health Association

American Association for Cancer Research

Professional Activities, Professional Service, and Organization

Peer Reviewer of Manuscripts

Cancer, 2019 – Present

Geriatrics, 2017 – Present

Value in Health, 2017 – Present

Health Education and Behavior, 2016 – Present


International Journal of Pharmacy Practice, 2016 – Present

Medical Care, 2015 – Present

American Journal of Men’s Health, 2015 – Present

Journal of Immigrant and Minority Heath, 2014 – Present

Committees

Dean Search – Howard University Graduate School, 2020-2021

Executive Board, University of Georgia Cancer Center, 2019-Present

University Council, University of Georgia, 2019-2022

Faculty Council, University of Georgia College of Pharmacy, 2018-2021

Vice President, University of Georgia Black Faculty and Staff Organization

Chair, University of Georgia Black Faculty and Staff Organization Scholarship Committee

Dean Search – University of Georgia College of Pharmacy, 2017-2018

University of Georgia College of Pharmacy Computer and Instructional Technology Committee, 2017-2018

University of Georgia College of Pharmacy Continuing Education and Outreach Committee, 2014-2016

Graduate Students Completed (Ph.D.) Abdulrahman A. Alwhaibi, PharmD (Dissertation Committee) – Summer 2019

Yu Wang, B.Pharm (Dissertation Committee) – Spring 2019

Surbhi Shah, B.Pharm, MS (Co-Dissertation Advisor/Committee) – Spring 2017

Shada Kanchanasuwan, PharmD (Dissertation Committee) – Fall 2017

Current Graduate Students (Ph.D.) Ibrahim Mohammed Asiri, PharmD (Dissertation Advisor/Major Professor)

Ijeoma Azih, MD, MPH (Dissertation Advisor/Major Professor)

Shaimaa Sabry Mohamed Elshafie, MS (Dissertation Advisor/Major Professor)


Farah Shahiq Pathan, B.Pharm (Dissertation Committee)

Asma Mahd Ali, PharmD (Dissertation Committee)

Leadership

Vice President, University of Georgia Black Faculty and Staff Organization

Mentor, University of North Carolina at Chapel Hill, Millennial Scholar Program, September 2013-August 2014

Introduction of Dr. Harold Varmus, 3rd Annual Oliver Smithies Nobel Symposium, University of North Carolina at Chapel Hill, April 2013

Mentor, University of North Carolina at Chapel Hill, Ronald E. McNair Scholars Program, January 2013-August 2014 (Sebastian Posada)

Leadership Committee, University of North Carolina at Chapel Hill, National Postdoctoral Association, September 2012-August 2014

Design Committee Chair, University of North Carolina at Chapel Hill, Oliver Smithies Nobel Symposium,

November 2012-April 2013

Mentor, University of North Carolina at Chapel Hill, Eshelman School of Pharmacy, September 2012-August 2014 (Robert Overman and Joshua C. Toliver)

Courses

Professional PharmD and PhD Curriculum

PHRM 8620 Pharmacy Care Administration Seminar – Fall 2020

PHRM 9000 Doctoral Research – Fall 2020

PHRM 4700 Statistical Approaches to Drug Literature Evaluation – Fall 2020

PHRM 8640 Research Methods in Pharmacy Care Administration – Fall 2020

PHRM 9000 Doctoral Research – Summer 2020

PHRM 5420 Pharmacy Health Services and Outcomes – Spring 2020

PHRM 9300 Doctoral Dissertation – Spring 2020

PHRM 3750 Pharmacy and US Health Care System – Spring 2020

PHRM 9000 Doctoral Research – Spring 2020



PHRM 9000 Doctoral Research – Spring 2019




PHRM 9000 Doctoral Research – Summer 2018


PHRM 8680 Pharmacoepidemiology – Spring 2018


PHRM 8620 Pharmacy Care Administration Seminar – Spring 2018

PHRM 8640 Research Methods in Pharmacy Care Administration – Fall 2017


PHRM 9300 Doctoral Dissertation – Fall 2017


PHRM 8640 Research in Pharmacy Administration – Fall 2016



PHRM 8680 Pharmacoepidemiology – Fall 2015

PHRM 8620 Pharmacy Administration Seminar – Spring 2015

PHRM 4130 Pharmacy Skills Lab IV – Spring 2015

Continuing Education

Harvard Medical School, Research Methods in Supportive Oncology, Dana-Farber Cancer Institute, Department of Psychosocial Oncology and Palliative Care

1. Behavioral Theories and Models, January 27, 2020

2. Development of Psychosocial Intervention, January 27, 2020

3. Clinical Trials, January 27, 2020

4. Palliative Care Research, January 27, 2020

5. Technology-Based Interventions, January 27, 2020

6. Approaches to Data Analysis, January 28, 2020

7. Qualitative Methods, January 28, 2020

8. Stakeholder Engagement, January 28, 2020

9. Implementation Science, January 29, 2020

10. Decision-Making Research, January 29, 2020

11. Communications Research, January 30, 2020


12. Research on Disparities and Cancer, January 30, 2020

13. Biomarkers in Symptom Research, January 30, 2020

14. Caregiver Research, January 30, 2020

15. Grant Proposal Writing, January 30, 2020

National Cancer Institute, Division of Cancer Prevention, Cancer Prevention Fellowship Program – Summer Curriculum in Molecular Cancer Prevention and Control

1. Molecular Basis of Carcinogenesis, August 5, 2019

2. Principles of Pathology and Epidemiological Research: More Than Meets the Eye, August 5, 2019

3. miRNAs in Mammalian Physiology and Disease, August 5, 2019

4. Applying Molecular Markers within Population-based Studies, August 6, 2019

5. Epigenetics in the Precision Medicine Era, August 7, 2019

6. Human Microbiome and Cancer Prevention, August 7, 2019

7. Nutrigenomics, August 8, 2019

8. Metabolomics and Cancer, August 8, 2019

9. Reproducibility in Omics Studies, August 8, 2019

10. Telomeres and Cancer, August 8, 2019

11. Applying Lung Cancer Radiomics Across the Cancer Continuum, August 9, 2019

12. Cancer Immunoprevention, August 9, 2019

13. Translational Genomics, August 9, 2019 University of North Carolina, Odum Institute for Research in Social Science, Qualitative Research Summer Intensive

1. Coding and Analyzing Qualitative Data, July 2019

2. Qualitative Analysis: Using the “Sort and Sift, Think and Shift” Toolkit, July 2019 National Cancer Institute, Division of Cancer Prevention, Cancer Prevention Fellowship Program – Summer Curriculum in Cancer Prevention and Control

1. Cancer Prevention from a Behavioral Science Perspective, July 10, 2017

2. The Science of Cancer Prevention, July 10, 2017

3. Analysis and Bias in Epidemiology Studies, July 11, 2017

4. Observational and Experimental Study Design, July 11, 2017

5. Introduction to Epidemiology and Descriptive Statistics, July 11, 2017

6. Social Determinants of Health in Cancer Control, July 12, 2017


7. Cancer Surveillance, July 13, 2017

8. International Cancer Research Networks, July 14, 2017

9. Obesity and Cancer, July 17, 2017

10. Physical Activity and Cancer Prevention, July 18, 2017

11. Environmental Pollutants and Cancer, July 19, 2017

12. "Re-visiting the Causes of Cancer", July 20, 2017

13. Interpreting Screening Data, July 20, 2017

14. The U.S. Preventive Services Task Force Program, July 20, 2017

15. Interpreting Scientific Evidence for Cancer Prevention, July 21, 2017

16. Cancer Risk Modeling, July 21, 2017

17. Community-based Cancer Prevention Research, July 24, 2017

18. The Challenge of Cancer Avoidance, July 25, 2017

19. Prostate Cancer, July 26, 2017

20. A Missing Piece in Cancer Control: Literacy and Health Literacy, July 27, 2017

21. Health Services Research in Cancer Control, July 31, 2017

22. Cancer Survivorship, August 1, 2017

23. Cancer Screening, August 2, 2017

24. Dissemination and Implementation Research in Health, August 3, 2017 University of Oxford, Center for Statistics in Medicine, Real World Data Epidemiology – Summer School

1. Study Designs in Real Word Data Epidemiology, June 19, 2017

2. Data Discovery, June 19, 2017

3. Missing Data, June 20, 2017 4. Validation Studies, June 20, 2017

5. Advanced Methods in Pharmacoepidemiology: Propensity Scores, Disease Risk Scores, and Instrumental Variables, June 21, 2017

6. Health Economics Using Real World Data, June 21, 2017

7. Pharmacoepidemiology, June 21, 2017

8. Data Management and Harmonization, June 22, 2017

9. Predication Modeling and Big Data Methods, June 22, 2017

10. Introduction to Device Epidemiology, June 23, 2017

11. Time Series Analysis, June 23, 2017


University of Michigan, School of Public Health, Office of Public Health Practice

1. Community-Based Participatory Research: Leave Your Parachute at Home, March 2015

2. Community-Based Participatory Research to Reduce Cancer Disparities: Promise and Pitfalls,

December 2016

3. Managing Chronic Diseases: Community and Population-Level Approaches, December 2016

4. Economic Evaluation for Public Health, December 2016

5. How to Understand and Implement Health Literacy, December 2016 Winship Cancer Institute at Emory University

1. Cancer Prevention & Control Program – Monthly Seminar, August 2015 – Present.

2. Prostate Cancer Research Program, December 2016 – Present. International Society for Pharmacoeconomics and Outcomes

1. Design and Analysis of Observational Studies of Treatment Effects Using Retrospective Data, May 2016

2. Applications in Using Large Databases, May 2016

3. Advanced Patient-Reported Outcomes, May 2016

ewan k. cobran, ph.d. curriculum vitae...ewan k. cobran, ph.d. curriculum vitae page 3 depression...

Documents